Page last updated: 2024-10-23

bendroflumethiazide and Bone Loss, Osteoclastic

bendroflumethiazide has been researched along with Bone Loss, Osteoclastic in 2 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoffersen, J1
Christoffersen, MR1
Jorgensen, FS1
Nielsen, SP1

Other Studies

2 other studies available for bendroflumethiazide and Bone Loss, Osteoclastic

ArticleYear
The effect of bendroflumethiazide and hydrochlorothiazide on the rate of dissolution of calcium hydroxyapatite.
    Calcified tissue international, 1984, Volume: 36, Issue:4

    Topics: Bendroflumethiazide; Bone Resorption; Durapatite; Humans; Hydrochlorothiazide; Hydrolysis; Hydroxyap

1984
Effects of long-term administration of bendroflumethiazide on bone metabolism in the rat.
    Acta pharmacologica et toxicologica, 1972, Volume: 31, Issue:5

    Topics: Animals; Bendroflumethiazide; Bone and Bones; Bone Matrix; Bone Resorption; Calcium; Calcium Isotope

1972